ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Bernard Fisher Settles Suit For $2.7M, Retains title, University Apologizes

September 5, 1997

Eight CCRU, 20 CCSP Applications Submitted, Quality Is ‘Heartening’

November 19, 1982

Former kidney cancer advocate Carl Dixon charged with theft of $335,000 from association.

October 3, 2003

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010